The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
Tumor immune escape is associated with the loss of tumor HLA class I (HLA-I) expression commonly found in malignant cells. Accumulating evidence suggests that the efficacy of immunotherapy depends on the expression levels of HLA class I molecules on tumors cells. It also depends on the molecular mec...
Main Authors: | Federico Garrido, Francisco Perea, Mónica Bernal, Abel Sánchez-Palencia, Natalia Aptsiauri, Francisco Ruiz-Cabello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/5/1/7 |
Similar Items
-
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
by: Hernani Gil-Julio, et al.
Published: (2021-07-01) -
Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer
by: Sarah A. Penny, et al.
Published: (2021-08-01) -
Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
by: Biaoru Li
Published: (2022-10-01) -
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival
by: P. S. Zeiner, et al.
Published: (2018-03-01) -
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
by: Yueshui Zhao, et al.
Published: (2022-08-01)